C23H28N8O4
Neat
480.53
Copanlisib; 1032568-63-0; BAY 80-6946; BAY-80-6946; BAY80-6946; BAY 80-6946 (Copanlisib); Aliqopa; 2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2, 3-dihydroimidazo[1, 2-c]quinazolin-5-yl)pyrimidine-5-carboxamide; 2-Amino-N-[2, 3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1, 2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide; MFCD18633201; WI6V529FZ9; Copanlisib (BAY 80-6946); C23H28N8O4; 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2, 3-dihydro-1H-imidazo[1, 2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide; 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2, 3-dihydroimidazo[1, 2-c]quinazolin-5-yl]pyrimidine-5-carboxamide; Copanlisib [INN]; copanlisibum; UNII-WI6V529FZ9; 2-AMINO-N-(7-METHOXY-8-(3-MORPHOLIN-4-YLPROPOXY)-2, 3-DIHYDROIMIDAZO(1, 2-C)QUINAZOLIN-5-YL)PYRIMIDINE-5-CARBOXAMIDE; 2-amino-N-[7-methoxy-8-(3-morpholinopropoxy)-2, 3-dihydroimidazo[1 and 2-c]quinazolin-5-yl]pyrimidine-5-carboxamide
2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2, 3-dihydro-1H-imidazo[1 and 2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide
InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14,25H,2,5-12H2,1H3,(H2,24,26,27)